The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
CONSTELLATION PHARMCETICLS I | COM | 210373106 | 4,033 | 128,307 | SH | SOLE | 0 | 0 | 128,307 | ||
JBG SMITH COM | COM | 46590V100 | 56,015 | 1,759,817 | SH | SOLE | 0 | 0 | 1,759,817 | ||
SQUARE INC | COM | 852234103 | 4,293 | 81,960 | SH | SOLE | 0 | 0 | 81,960 | ||
TRANSDIGM GROUP INC | COM | 893641100 | 7,623 | 23,807 | SH | SOLE | 0 | 0 | 23,807 | ||
UBER TECHNOLOGIES INC | COM | 90353T100 | 1,432 | 51,288 | SH | SOLE | 0 | 0 | 51,288 |